Study finds new clues into what caused blood clots in AstraZeneca vaccine recipients

Kendall Tietzm DCNF

A group of Canadian researchers published a study Wednesday highlighting a previously unknown link between certain amino acids and rare blood clots in AstraZeneca COVID-19 vaccine recipients.

Researchers said it could assist doctors in identifying and treating the blood clots which result from an immune-driven mix of coagulation and loss of platelets that stop bleeding, the Wall Street Journal reported. A team of researchers at McMaster University in Ontario published the findings in the Nature scientific journal, which builds on recent research in Europe about blood clots associated with the vaccine, and some scientists call vaccine-induced immune thrombotic thrombocytopenia (VITT).

AstraZeneca vaccine recipients first reported blood clots in the spring and the shot has been widely used in European countries. VITT has killed 170 vaccinated adults in the U.K, Europe and the U.S. according to government data, the WSJ reported.

VITT has also been seen in the Johnson & Johnson vaccine, but at much lower rates, the WSJ reported. Many of those impacted by blood clots were young and healthy before they received the vaccine, according to researchers and drug regulators.

Researchers and regulators have weighed the vaccine factors and determined the benefits still outweigh the risks, the European Medicine Agency said in March. Researchers want to understand the link between low blood platelets and blood clots with the vaccines to diagnose and prevent the condition more quickly, which might be possible by altering the makeup of the shot, the WSJ reported. 

For licensing opportunities of our original content, please contact licensing@dailycallernewsfoundation.org.

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.

BPR INSIDER COMMENTS

Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!

Latest Articles